Population Pharmacokinetic and Pharmacodynamic Modeling Analysis of rhIL-7-hyFc, a Hybrid Fc-Fused Long-Acting Interleukin-7, to Support Optimal Dosing Regimens in Patients with Solid Cancer

Park S, Lee SM, Pak KC, Byun MS, Choi D, Lim HS

Drug Design, Development and Therapy 2025, 19:9303-9320

Published Date: 17 October 2025